Obesity-associated hypertension: Hypothesized link between etiology and selection of therapy

Blood Pressure Monitoring

Volumn 4, Issue SUPPL. 1, 1999, Pages

  Neutel, Joel M ^a   Smith, David H G ^a   Weber, Michael A ^b  

^a Orange County Heart Institute and Research Center   (United States)

^b BROOKDALE UNIVERSITY HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Antihypertensive treatment; Hypertension; Obesity

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; METOPROLOL; NIFEDIPINE; PRAZOSIN;

AORTA ROOT; BLOOD VOLUME; CLINICAL TRIAL; CONFERENCE PAPER; DRUG CHOICE; GLOMERULUS; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE MASS; HEART OUTPUT; HEART VENTRICLE SEPTUM; HEMODYNAMICS; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; KIDNEY INTERSTITIUM; KIDNEY MEDULLA; KIDNEY TUBULE; META ANALYSIS; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PRIORITY JOURNAL; VASCULAR RESISTANCE; WEIGHT REDUCTION;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; HUMANS; HYPERTENSION; OBESITY;

EID: 0342748642     PISSN: 13595237     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (19)

1. Weber MA, Drayer JIM. The circadian blood pressure pattern in ambulatory normal subjects. Am J Cardiol 1984; 54:115-119.
2. Linsell CR. Circadian rhythms of epinephrine and norepinephrine in man. J Clin Endocrinol Metab 1985; 66:1210-1215.
3. Messerli FH. Diurnal variations of cardiac rhythm, arterial pressures and urinary catecholarines in borderline and established essential hypertension. Am Heart J 1992; 104:109-113.
4. Marler JR, Price TR, Clark GL. Morning increase in onset of ischemic stroke. Stroke 1989; 20:473-476.
5. Muller JE, Stone PH, Turi ZG. Orcadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med 1985; 313:131J-132J.
6. Tofler GH, Brezinski D, Schafer AL. Concurrent morning increases in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med 1987; 316:1514-1518.
7. Deedwania PC, Nelson JR. Pathophysiology of silent myocardial ischemia during daily life: hemodynamic evaluation by simultaneous electrocardiographic and blood pressure monitoring. Circulation 1990; 82:1296-1304.
8. Parati G, Pomidossi G, Albini F, Malaspina D, Mancia G. Relationship of 24-hour blood pressure mean and variability to severity of target organ damage in hypertension. J Hypertens 1987; 5:93-98.
9. Davies MJ, Thomas AC. Plaque fissuring the cause of acute myocardial infarction, sudden ischemic death and crescendo angina. Br Heart J 1985; 53:363-373.
10. Falk E. Plaque rupture with severe pre-existing stenosis precipitating coronary occlusive thrombi. Br Heart J 1983; 50:127-134.
11. Neutel JM, Smith DHG, Lefkowitz MP, Cargo P, Alemayehu D, Weber MA. Hypertension in the elderly: 24-h ambulatory blood pressure results from a placebo controlled trial. J Hum Hypertens 1995; 9:723-727.
12. White WB. Relevance of the trough-to-peak ratio to the 24 hour blood pressure load. Am J Hypertens 1996; 9:915-965.
13. White WB. Ambulatory blood pressure and target organ involvement in hypertension. Clin Invest Med 1991; 14:224-230.
14. Elliot HL, Meredith PA. Trough:peak ratio: clinically useful or practically irrelevant? J Hypertens 1995; 13:279-283.
15. Morgan T, Menard J, Brunner H. Trough to peak ratio as a guide to BP control: measurement and calculation. J Hum Hypertens 1998; 12:49-53.
16. Neutel JM, Smith DHG. Dose response and antihypertensive efficacy of the 18AT1 receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 1998; 15:229-234.
17. Lacourciere Y, Lenis J, Orchard R, Lewancyuk R. A comparison of the efficacy and duration of action of the angiotensin II receptor blocker telmisartan to amlodipine. Blood Press Monit 1998; 3:295-302.
18. Mallion JM, Lacourciere Y. ABPM comparison of the antihypertensive profiles of the selective angiotensin II receptor antagonísts telmisartan and losartan in patients with mild to moderate hypertension. J Hum Hypertens 1999; 13:657-664.
19. Neutel JM, Schaper H, Weber MA. Antihypertensive effects of beta blockers administered once daily: 24h measurements. Am Heart J 1990; 120:166-171.